DNA Therapeutics for Cancer Treatment

Companies
Categories
Subcategories
What they say about it

In partnership with Intrexon Corporation, ZIOPHARM is developing two clinical-stage DNA therapeutics, and is exploring a number of applications for this revolutionary technology in the lab, including controlled production in the body of therapeutic antibodies, immune-toxins and protein decoys. We have multiple programs under development and expect to file at least eight investigational new drug, or IND, applications through 2015.

Country of Origin
Market Status
Websites
www.ziopharm.com